Golodirsen Shows Potential to Treat DMD
Sarepta announced encouraging results from a phase 1/2 DMD clinical trial for golodirsenm which targets exon 53.
Sarepta announced encouraging results from a phase 1/2 DMD clinical trial for golodirsenm which targets exon 53.
Dr. Mattia Quattrocelli of Northwestern University was awarded an MDA grant to study the effects of glucocorticoids in DMD.
Tejvir Khurana, a professor at the University of Pennsylvania was awarded an MDA grant to test a therapeutic strategy for DMD.
Postdoctoral associate James Novak was awarded an MDA grant totaling $180,000 to study exon skipping drugs in DMD.
Erik Storkebaum, of the Max Planck Institute for Molecular Biomedicine in Germany, is studying the underlying mechanisms that drive CMT.
Kleopas Kleopa, professor at Cyprus School of Molecular Medicine, received an MDA grant to test a treatment in CMT1X
In October 1986 Jerry Lewis announced the DMD gene had been discovered, a monumental moment in MD research.
MDA has awarded a human clinical trial grant to Nicholas Johnson, M.D., to conduct a natural history study in congenital DM1.
Monkol Lek, a researcher at Massachusetts General Hospital and the Broad Institute, both lives with and studies limb girdle muscular dystrophy. He received a research grant from MDA to improve the diagnosis of rare muscle diseases, and this fall he will open his own lab at Yale.
Results from an MDA-supported study show that resistance exercise not only is safe, but can help reduce muscle weakness experienced by people with CMT.